Experimental studies demonstrated that AAL improved trinitro-benzene-sulfonic acid (TNBX)-induced ulcerative colitis in rats by inhibiting inflammatory cell infiltrates, and decreasing the MPO activity and frequency of diarrhea (9). Here, MPO is linked to ulcerative colitis.